Core Viewpoint - The company has approved the use of idle self-owned funds for entrusted wealth management to enhance the efficiency of fund utilization and increase returns for the company and its shareholders [2][10]. Investment Overview - Investment Purpose: The company aims to improve the efficiency of idle self-owned funds without affecting normal business operations, thereby increasing returns for the company and its shareholders [4]. - Investment Amount: The company has set an upper limit of RMB 2.9 billion for investments in wealth management products, which can be rolled over within this limit [5][10]. - Source of Funds: The funds will come from the idle self-owned funds of the company and its consolidated subsidiaries [6]. - Investment Method: The company will select qualified financial institutions with good credit and financial status to act as trustees, ensuring no related party transactions occur [7]. - Investment Duration: The approved investment limit is valid for 12 months from the date of the board's approval [9][10]. Review Procedures - The board of directors held a meeting on January 30, 2026, to approve the proposal for using idle self-owned funds for entrusted wealth management, which does not require shareholder approval [2][10][16]. Impact on the Company - The use of idle self-owned funds for entrusted wealth management will not affect the company's daily operations and is expected to enhance returns for both the company and its shareholders [13].
健康元药业集团股份有限公司关于使用闲置自有资金进行委托理财的公告